| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |